OneAscent Financial Services LLC Buys 425 Shares of CVS Health Co. (NYSE:CVS)

OneAscent Financial Services LLC boosted its stake in shares of CVS Health Co. (NYSE:CVS) by 6.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,032 shares of the pharmacy operator’s stock after buying an additional 425 shares during the quarter. OneAscent Financial Services LLC’s holdings in CVS Health were worth $561,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Atticus Wealth Management LLC raised its holdings in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 219 shares in the last quarter. USA Financial Formulas raised its holdings in shares of CVS Health by 573.2% in the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health in the 4th quarter valued at about $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $34,000. Finally, Steph & Co. raised its holdings in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In other news, Director Edward J. Ludwig bought 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.24% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of several recent research reports. Argus reduced their price target on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Truist Financial reaffirmed a “buy” rating and issued a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research report on Thursday, May 2nd. TD Cowen downgraded shares of CVS Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $99.00 to $59.00 in a research report on Tuesday, May 7th. Wells Fargo & Company cut their price objective on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 7th. Finally, Bank of America cut their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Eleven equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $75.05.

CVS Health Stock Up 1.2 %

CVS stock opened at $59.06 on Friday. The firm’s fifty day simple moving average is $59.56 and its 200-day simple moving average is $70.17. The company has a market capitalization of $74.14 billion, a P/E ratio of 10.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the company earned $2.20 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. As a group, equities research analysts forecast that CVS Health Co. will post 7.02 earnings per share for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.